REFERENCES
- Luca S, Mihaescu T. History of BCG Vaccine. Maedica (Bucur)
2013;8:53-8.
- Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus
Calmette-Guerin in the treatment of superficial bladder tumors. J Urol
1976;116:180-3.
- Lamm DL. Efficacy and safety of bacille Calmette-Guérin immunotherapy
in superficial bladder cancer. Clin Infect Dis 2000;31(Suppl
3):S86-90.
- Kawai K, Miyazaki J, Joraku A, Nishiyama H, Akaza H. Bacillus
Calmette-Guerin (BCG) immunotherapy for bladder cancer: current
understanding and perspectives on engineered BCG vaccine. Cancer Sci
2013;104:22-7.
- Koch GE, Smelser WW, Chang SS. Side effects of Intravesical BCG and
Chemotherapy for Bladder Cancer: What They Are and How To Manage Them.
J Urol 2021;149:11-20.
- Abu-Nader R, Terrell CL. Mycobacterium bovis vertebral osteomyelitis
as a complication of intravesical BCG use. Mayo Clinic Proceedings
2002;77:393-7.
- Pérez-Jacoiste Asín MA, Fernández-Ruiz M, López-Medrano F, Lumbreras
C, Tejido Á, San Juan R, et al . Bacillus Calmette- Guérin (BCG)
infection following intravesical BCG administration as adjunctive
therapy for bladder cancer. Medicine 2014;93:236-54.